Comparison 5. Oxcarbazepine versus placebo.
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
1 Aggression (self‐reported): OAS‐M‐revised, number of responders as > 49% reduction in Global Overt Aggression score, at 10 wks | 1 | 45 | Odds Ratio (M‐H, Fixed, 95% CI) | 4.88 [1.36, 17.47] |
2 Non‐compliance: leaving the study early, any reason | 1 | 48 | Odds Ratio (M‐H, Fixed, 95% CI) | 0.51 [0.16, 1.61] |
3 Non‐compliance: leaving the study early, due to adverse events | 1 | 48 | Odds Ratio (M‐H, Fixed, 95% CI) | 2.33 [0.51, 10.69] |
4 Non‐compliance: leaving the study early, due to ineffectiveness | 1 | 48 | Odds Ratio (M‐H, Fixed, 95% CI) | 0.24 [0.06, 0.90] |